1.
U.S. markets recover from steep losses
FREMONT, Calif., Jan. 4 (UPI) -- A unit of Johnson & Johnson disclosed two additional deaths of patients in a clinical trial of its heart drug Natrecor, a report said Wednesday.
The disclosure added to safety questions already clouding the mediation meant to treat heart failure made by the Johnson & Johnson unit Scios, The New York Times reported.
With the two additional deaths, Scios said seven patients died during the drug trial. But the company said that did not change safety assumptions about Natrecor.
Neither Scios nor the principal investigator, Dr. W. Franklin Peacock of Cleveland Clinic, disclosed how the deaths were omitted from results reported in October in The Journal of Emergency Medicine.
A Cleveland Clinic spokeswoman said Peacock believed the deaths, which were discovered in September, were accidental and unrelated to the drug.
"When you're talking deaths in clinical trials, mistakes are not an option," Dr. Arthur Caplan, a University of Pennsylvania medical ethicist, told the Times.
|
|
|
|
|
|
| Additional Business News Stories | |
WASHINGTON, May 23 (UPI) --
The planned Keystone XL oil pipeline would move oil away from refineries that produce gasoline, increasing prices, the National Resource Defense Council says.
|
MELBOURNE, Fla., May 23 (UPI) --
Northrop Grumman says its Military Airworthiness Certification is closer for its re-engined EC-8 Joint Surveillance Target Attack Radar System aircraft.
|
The housing inventory rose slightly in April, which is unusual in the middle of the spring sales season. The uptick may be the result of rising seller confidence and it should ease concerns that the super tight inventory levels of the last six months...
|
What if Europe turned out to be the new Japan?
|
| Stories | Photos | People | Comments |
View Caption
